ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 40 of 104 for:    Recruiting, Not yet recruiting, Available Studies | "Muscular Dystrophies"

Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03589612
Recruitment Status : Recruiting
First Posted : July 18, 2018
Last Update Posted : July 18, 2018
Sponsor:
Information provided by (Responsible Party):
Lütfiye AKKURT, Hacettepe University

Brief Summary:
Investigator investigated that regression of hamstring flexibility and performance in children with Duchenne Muscular Dystrophy.

Condition or disease
Duchenne Muscular Dystrophy Performance Flexibility

Detailed Description:
Flexibility of hamstrings was evaluated by Popliteal Angle test. Performance was evaluated 6 Minute Walk Test (6 MWT). Regression of hamstring flexibility and performance was examined regression tests.

Study Type : Observational
Estimated Enrollment : 42 participants
Observational Model: Other
Time Perspective: Other
Official Title: Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy
Actual Study Start Date : March 8, 2018
Estimated Primary Completion Date : November 30, 2018
Estimated Study Completion Date : December 30, 2018





Primary Outcome Measures :
  1. Popliteal Angle Test [ Time Frame: 5 minute ]
    The Popliteal Angle Test was used to assess hamstring flexibility. Child asked to rise lower leg straight. Incomplete angle degree of full extension is popliteal angle.


Secondary Outcome Measures :
  1. 6 Minute Walk Test [ Time Frame: 6 minute ]
    6 Minute Walk Test was used to assess performance with children Duchenne MUscular Dystropy.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years to 14 Years   (Child)
Sexes Eligible for Study:   Male
Sampling Method:   Probability Sample
Study Population
Sixty children will participated this study. Fourty-two children was assessed, and eighteen children will assess in a few months.
Criteria

Inclusion Criteria:

  • To be a Duchenne Muscular Dystrophy diagnosis,
  • Being in the ambulatory period and climbing four steps independently,
  • to be Level 1 and Level 2 according to Brooke Lower Functional Classification Test
  • To be able to cooperate
  • No any severe contracture in the lower limbs which may prevent assessments,

Exclusion Criteria:

  • Children who fail to meet these criteria study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03589612


Contacts
Contact: Lütfiye Akkurt, MsC 905548521081 fzt.lutfiyeakkurt@gmail.com
Contact: Oznur Yılmaz, Prof. +903123051576 ext 145 oznurtunca@yahoo.com

Locations
Turkey
Hacettepe University Recruiting
Ankara, Sıhhiye, Turkey
Contact: Öznur Yılmaz, Prof.    +903123051576 ext 145    oznurtunca@yahoo.com   
Contact: Lütfiye Akkurt, MSc    905548521081    fzt.lutfiyeakkurt@gmail.com   
Sponsors and Collaborators
Hacettepe University
Investigators
Principal Investigator: Güllü Aydın, Msc. Hacettepe University
Principal Investigator: Numan Bulut, Msc Hacettepe University
Principal Investigator: İpek Gürbüz, Assoc.Prof. Hacettepe University
Principal Investigator: Ayşe Karaduman, Prof. Hacettepe University

Responsible Party: Lütfiye AKKURT, Principal investigator, Hacettepe University
ClinicalTrials.gov Identifier: NCT03589612     History of Changes
Other Study ID Numbers: GO 16/740-2
First Posted: July 18, 2018    Key Record Dates
Last Update Posted: July 18, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Lütfiye AKKURT, Hacettepe University:
Duchenne Muscular Dystrophy
performance
hamstring flexibility
regression

Additional relevant MeSH terms:
Muscular Dystrophies
Muscular Dystrophy, Duchenne
Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Genetic Diseases, Inborn
Genetic Diseases, X-Linked